How the Immune System Learns Self-Tolerance

Microscopic immune cells interacting calmly with healthy human tissue

How the Immune System Learns Self-Tolerance Explainer

The immune system must recognize an enormous range of threats without attacking the body that contains it. Because antigen receptors are assembled through partly random genetic rearrangement, some developing lymphocytes will inevitably recognize self molecules. Tolerance is the collection of processes that deletes, redirects, disables, or restrains those potentially harmful cells while preserving useful defenses.

Central tolerance begins where lymphocytes develop. Immature T cells in the thymus are exposed to many self antigens. Cells that bind too strongly are often eliminated, while some become regulatory T cells. B cells undergo related screening in bone marrow and may die, become inactive, or revise their receptor through receptor editing if they strongly recognize self.

Central screening is extensive but not complete because no tissue can display every self molecule in every possible form. Peripheral tolerance controls mature cells that escape. A lymphocyte that recognizes an antigen without the correct costimulatory signals may enter a long-lasting unresponsive state called anergy or undergo programmed cell death instead of launching an attack.

Regulatory T cells provide active restraint. They consume growth signals, release inhibitory molecules, and influence antigen-presenting cells and nearby lymphocytes. Immune checkpoints also reduce activation after a response has begun. Tissues such as the eye, brain, placenta, and intestine add specialized barriers and local signals that limit damaging inflammation.

Tolerance is not simple ignorance. The immune system continually balances receptor binding, context, tissue damage, microbial signals, and regulatory input. Infection, inherited variants, altered self proteins, or tissue injury can disturb that balance. Molecular similarity between a microbe and a self antigen may also contribute to cross-reactive responses in susceptible people.

When multiple safeguards fail, self-reactive cells can drive autoimmune disease. When restraint is too strong, infections or tumors may escape. Treatments therefore aim in opposite directions depending on the problem: strengthen inhibition in autoimmunity and transplantation, or release selected brakes in cancer. The goal is precise control, because completely suppressing or unleashing immunity can both be dangerous.

Random receptor formation creates some self-reactive lymphocytes, so tolerance is an expected requirement rather than an exception.

The thymus and bone marrow remove, edit, redirect, or silence many self-reactive cells during development.

Peripheral cells that see antigen without proper context can become anergic or undergo programmed death.

Regulatory T cells and checkpoint molecules actively restrain immune activation in tissues.

Genes, infection, tissue damage, and cross-reactive antigens can weaken the balance and contribute to autoimmunity.

Therapy may strengthen tolerance for autoimmune disease or loosen selected brakes so immunity can attack cancer.

Explore more "Explainers"

Discover additional explainers across politics, science, business, technology, and other fields. Each explainer breaks down a complex idea into clear, everyday language—helping you better understand how major concepts, systems, and debates shape the world around us.